The FDA will hold a panel next month in an effort to better evaluate the safety of medical device implants.
The agency's first public advisory committee meeting seeks input from experts and the public on medical device safety. The agency is requesting experts bring new information on scientific evidence about materials used in medical devices.
The agency said it has been evaluating a growing body of evidence suggesting some patients with device implants may have adverse reactions to the materials in implants. Some adverse events that have been reported to the FDA include inflammatory reactions and tissue changes that cause pain and fatigue.
The goal of the panel is to determine ways to better identify patients at risk of an adverse reaction to a medical device implant.
The Immunology Devices Panel meeting of the FDA's Medical Devices Advisory Committee will be held Nov. 13- 14.
The panel of experts can provide input on what the FDA should consider as part of its premarket review and postmarket surveillance of medical device implants.
Read the full news release here.